Proponents of the plan to equip paramedics with buprenorphine call it the "missing link" in the bridge to recovery for many ...

Texas and 14 other states have secured a $7.4 billion settlement from the Sackler family and their company, Purdue Pharma, ...

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to developing therapies for rare and complex central nervous ...

The money could benefit the 14 syringe service programs across the five boroughs that offer harm reduction services.

Reversing opioid overdoses in rats using a drug that does not enter the brain prevents the sudden and severe withdrawal symptoms associated with therapeutics that target the central nervous system.

During the COVID-19 pandemic, when fentanyl overdoses surged, doctors were desperate to find ways of helping their patients.

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

The program's expansion is being funded by money Orange County received through national legal settlements with opioid ...

Whatcom County Health and Community Services has partnered with the Swinomish tribe’s didgʷálič Wellness Center to bring a ...

These funds will provide medication assisted treatment, offering more detox ... and similar medications to reduce the sickness from opioid withdrawal. The county has seen some progress, with ...

The latest health briefs reveal Novo Nordisk's promising obesity treatment and a $7.4 billion Purdue Pharma settlement over ...

A new study from researchers at UC San Francisco has found that a treatment approach designed to help people addicted to fentanyl, using low doses of buprenorphine, is not working as expected. The ...